Yes, but it is always best to consult your healthcare provider to avoid any potential interactions or overdosing on certain nutrients
Back to Journals Journal of Hepatocellular Carcinoma Volume 12 Natural Bioactive Compounds Targeting the Wnt/-Catenin Pathway for the Treatment of Hepatocellular Carcinoma Authors Tian H, Wang P, Shao H Received 19 February 2025 Accepted for publication 11 July 2025 Published 23 July 2025 Volume 2025:12 Pages 16131622 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Ali Hosni Haoyu Tian, Peng Wang, Haibo Shao Department of Interventional Radiology, The First Hospital of China Medical University, Shenyang, Liaoning, Peoples Republic of China Correspondence: Haibo Shao, Department of Interventional Radiology, The First Hospital of China Medical University, Shenyang, Peoples Republic of China, Email [email protected] Abstract: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with limited treatment options and poor prognosis
Um eine Krankheit festzustellen, die sich nicht feststellen lsst, mssen rzte ausschlieen, dass ein Patient andere Krankheiten hat, die seine Beschwerden ebenso verursachen knnten das heit Ausschlussdiagnose
Moreover, the absence of active-placebo controls in polyphenol or vitamin trials raises the possibility of performance bias, particularly when subjective endpoints such as VAS are used (Pop-Busui et al., 2017)
